Carregant...

Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide

Non-viral gene delivery systems have gained considerable attention as a promising alternative to viral delivery to treat diseases associated with aberrant gene expression. However, regardless of extensive research, only a little is known about the parameters that underline in vivo use of the nanopar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kurrikoff, Kaido, Veiman, Kadi-Liis, Künnapuu, Kadri, Peets, Elin Madli, Lehto, Tõnis, Pärnaste, Ly, Arukuusk, Piret, Langel, Ülo
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719086/
https://ncbi.nlm.nih.gov/pubmed/29213085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-17316-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!